SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 398,364.39 |
| Enterprise Value ($M) | 423,896.39 |
| Book Value ($M) | 74,599.00 |
| Book Value / Share | 28.54 |
| Price / Book | 5.34 |
| NCAV ($M) | -55,280.00 |
| NCAV / Share | -21.15 |
| Price / NCAV | -7.21 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.16 |
| Return on Assets (ROA) | 0.10 |
| Return on Equity (ROE) | 0.26 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.77 |
| Current Ratio | 0.99 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 55,294.00 |
| Assets | 187,378.00 |
| Liabilities | 110,574.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 94,943.00 |
| Operating Income | 25,673.00 |
| Net Income | 17,941.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 21,194.00 |
| Cash from Investing | -12,371.00 |
| Cash from Financing | -8,871.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | State Street Corp | 5.45 | -1.76 | |
| 13G/A | Vanguard Group Inc | 9.44 | 5.13 | |
| 13G/A | BlackRock Inc. | 7.60 | -0.61 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,129,586 | 8,919,373 | 12.66 | |
| 520,580 | 5,596,404 | 9.30 | |
| 447,674 | 5,132,769 | 8.72 | |
| 584,632 | 5,420,836 | 10.78 | |
(click for more detail) |
|||